Abstract
Adequate blood pressure (BP) management poses a significant challenge in improving the prognosis of patients undergoing dialysis. We aimed to investigate the relationship between pre-dialysis systolic blood pressure (SBP) and underlying disease in Japanese patients undergoing dialysis, based on prefectural location, and assess the association between pre-dialysis SBP and cardiovascular disease (CVD) mortality rate. We extracted the basic information of 336,182 patients who were undergoing dialysis in 2021 from the Web-based Analysis of Dialysis Data Archives database. Data on average pre-dialysis SBP were analyzed according to sex, prefectural location, and diabetic status, and the CVD mortality rate for each prefecture was calculated. The mean pre-dialysis SBP of the patients (males, 66.3%; mean age, 69.7 ± 12.5 years) was 151.9 ± 24.7 mmHg. Overall, 133,037 patients had underlying diabetic kidney disease (DKD). The patients with DKD were younger, had a shorter dialysis duration, and a higher pre-dialysis SBP than those with non-DKD comorbidities. The prefecture-based mean pre-dialysis SBP values were all higher than 140 mmHg. At the prefectural level, CVD mortality rate was positively correlated with pre-dialysis SBP (r = 0.3127, p = 0.0324) and diastolic blood pressure (r = 0.3378, p = 0.0202) among female patients. At the prefectural level, pre-dialysis SBP is >140 mmHg in Japanese patients undergoing dialysis, especially in those with DKD. The positive association between pre-dialysis SBP and CVD mortality rate suggests that optimal BP management at the prefectural level may reduce CVD mortality rates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nakagawa N, Hasebe N. Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia. Curr Hypertens Rep. 2019;21:2.
Nakagawa N, Matsuki M, Yao N, Hirayama T, Ishida H, Kikuchi K, et al. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in japanese patients undergoing hemodialysis. Ther Apher Dial. 2015;19:30–39.
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.
Kabutoya T, Hoshide S, Kario K. Asian management of hypertension: current status, home blood pressure, and specific concerns in Japan. J Clin Hypertens. 2020;22:486–92.
Iseki K, Nakai S, Shinzato T, Morita O, Shinoda T, Kikuchi K, et al. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Ther Apher Dial. 2007;11:183–8.
Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, et al. Annual dialysis data report 2017, JSDT Renal Data Registry. Ren Replacement Ther. 2019;5:53.
Georgianos PI, Agarwal R. Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol. 2016;12:636–47.
Myers OB, Adams C, Rohrscheib MR, Servilla KS, Miskulin D, Bedrick EJ, et al. Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol. 2010;21:1970–8.
Nakagawa N, Sofue T, Kanda E, Nagasu H, Matsushita K, Nangaku M, et al. J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan. Sci Rep. 2020;10:7351.
Nagasu H, Yano Y, Kanegae H, Heerspink HJL, Nangaku M, Hirakawa Y, et al. Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the Japan chronic kidney disease database. Diabetes Care. 2021;44:2542–51.
Wakasugi M, Narita I. Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006-220. Nephrology. 2023;28:119–29.
Salman E, Kadota A, Okami Y, Kondo K, Yoshita K, Okuda N, et al. Investigation of the urinary sodium-to-potassium ratio target level based on the recommended dietary intake goals for the Japanese population: the INTERMAP Japan. Hypertens Res. 2022;45:1850–60.
Dahl LK. Possible role of salt intake in the development of essential hypertension. 1960. Int J Epidemiol. 2005;34:967–72. discussion 972-964, 975-968
Uechi K, Asakura K, Masayasu S, Sasaki S. Within-country variation of salt intake assessed via urinary excretion in Japan: a multilevel analysis in all 47 prefectures. Hypertens Res. 2017;40:598–605.
Schneider RH, Salerno J, Brook RD. 2020 International Society of Hypertension global hypertension practice guidelines - lifestyle modification. J Hypertens. 2020;38:2340–1.
Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13:981–93.
Banerjee D, Winocour P, Chowdhury TA, De P, Wahba M, Montero R, et al. Management of hypertension in patients with diabetic kidney disease: summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021. Kidney Int Rep. 2022;7:681–7.
Kiyoshige E, Ogata S, O’Flaherty M, Capewell S, Takegami M, Iihara K, et al. Projections of future coronary heart disease and stroke mortality in Japan until 2040: a Bayesian age-period-cohort analysis. Lancet Reg Health West Pac. 2023;31:100637.
Wakasugi M, Narita I. Sex differences in cause-specific mortality in Japanese dialysis patients. Intern Med. 2022;61:2831–9.
Acknowledgements
We thank the Committee of the Renal Data Registry of the Japanese Society for Dialysis Therapy (JSDT) for permission to use their registry data. The results of the present study were derived from the analysis of split data from the WADDA system of the JSDT. However, the interpretation and reporting of these data are the responsibilities of the authors and should not be viewed as official policies or interpretations of the JSDT. All the authors have approved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sakuma, H., Ikeda, M., Nakao, S. et al. Regional variation in pre-dialysis blood pressure and its association with cardiovascular mortality rates in Japanese patients undergoing dialysis. Hypertens Res 47, 102–111 (2024). https://doi.org/10.1038/s41440-023-01415-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01415-7
Keywords
This article is cited by
-
Pre-dialysis blood pressure and cardiovascular mortality in Japan: need for much stricter control?
Hypertension Research (2023)